![Hero Primary](/my/sites/default/files/2024-02/Hero%20Primary_1.png)
Unlocking the Next
Chapter of Kidney Care
Meet the Expert Series: Video On Demand-Prof. Michel Jadoul
What are your thoughts on the results of the primary outcome of the composite of kidney disease progression and cardiovascular death of Empagliflozin based on the EMPA-KIDNEY trial?
Related Videos
Document ID: SC-ASK-00216